Novartis Risk Adjusted Performance

NVSEF
 Stock
  

USD 84.01  5.21  6.61%   

Novartis risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Novartis Ag Basl or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
Refresh
Novartis Ag Basl has current Risk Adjusted Performance of (0.03474).
RAP 
 = 
(ER[a] - RFR) * STD[b])/STD[b] 
RFR 
 = 
(0.03474)
ER[a] = Expected return on investing in Novartis
RFR = Risk Free Rate of return. Typically T-Bill Rate
STD[b] =   Standard Deviation of selected market or benchmark.

Novartis Risk Adjusted Performance Peers Comparison

Novartis Risk Adjusted Performance Relative To Other Indicators

Novartis Ag Basl is rated below average in risk adjusted performance category among related companies. It is regarded second in maximum drawdown category among related companies .
Compare Novartis to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas